Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Issue Archive

Table of Contents

BLOOD COMMENTARIES

PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
CLINICAL TRIALS AND OBSERVATIONS
Lymphoid Neoplasia
Red Cells, Iron, and Erythropoiesis

PLENARY PAPER

PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS

BLOOD SPOTLIGHT

REVIEW ARTICLE

CLINICAL TRIALS AND OBSERVATIONS

HEMATOPOIESIS AND STEM CELLS

LYMPHOID NEOPLASIA

David Ghez,on behalf on the French Innovative Leukemia Organization (FILO) CLL group,Anne Calleja,on behalf on the French Innovative Leukemia Organization (FILO) CLL group,Caroline Protin,on behalf on the French Innovative Leukemia Organization (FILO) CLL group,Marine Baron,on behalf on the French Innovative Leukemia Organization (FILO) CLL group,Marie-Pierre Ledoux,on behalf on the French Innovative Leukemia Organization (FILO) CLL group,Gandhi Damaj,on behalf on the French Innovative Leukemia Organization (FILO) CLL group,Mathieu Dupont,on behalf on the French Innovative Leukemia Organization (FILO) CLL group,Brigitte Dreyfus,on behalf on the French Innovative Leukemia Organization (FILO) CLL group,Emmanuelle Ferrant,on behalf on the French Innovative Leukemia Organization (FILO) CLL group,Charles Herbaux,on behalf on the French Innovative Leukemia Organization (FILO) CLL group,Kamel Laribi,on behalf on the French Innovative Leukemia Organization (FILO) CLL group,Ronan Le Calloch,on behalf on the French Innovative Leukemia Organization (FILO) CLL group,Marion Malphettes,on behalf on the French Innovative Leukemia Organization (FILO) CLL group,Franciane Paul,on behalf on the French Innovative Leukemia Organization (FILO) CLL group,Laetitia Souchet,on behalf on the French Innovative Leukemia Organization (FILO) CLL group,Malgorzata Truchan-Graczyk,on behalf on the French Innovative Leukemia Organization (FILO) CLL group,Karen Delavigne,on behalf on the French Innovative Leukemia Organization (FILO) CLL group,Caroline Dartigeas,on behalf on the French Innovative Leukemia Organization (FILO) CLL group,Loïc Ysebaert,on behalf on the French Innovative Leukemia Organization (FILO) CLL group

RED CELLS, IRON, AND ERYTHROPOIESIS

TRANSPLANTATION

LETTERS TO BLOOD

Sabrina Giammarco,for the European Group for Blood and Marrow Transplantation Severe Aplastic Anemia Working Party,Régis Peffault de Latour,for the European Group for Blood and Marrow Transplantation Severe Aplastic Anemia Working Party,Simona Sica,for the European Group for Blood and Marrow Transplantation Severe Aplastic Anemia Working Party,Carlo Dufour,for the European Group for Blood and Marrow Transplantation Severe Aplastic Anemia Working Party,Gerard Socie,for the European Group for Blood and Marrow Transplantation Severe Aplastic Anemia Working Party,Jakob Passweg,for the European Group for Blood and Marrow Transplantation Severe Aplastic Anemia Working Party,Nicolaus Kröger,for the European Group for Blood and Marrow Transplantation Severe Aplastic Anemia Working Party,Eefke Petersen,for the European Group for Blood and Marrow Transplantation Severe Aplastic Anemia Working Party,Maria Teresa Van Lint,for the European Group for Blood and Marrow Transplantation Severe Aplastic Anemia Working Party,Rosi Oneto,for the European Group for Blood and Marrow Transplantation Severe Aplastic Anemia Working Party,Alessio Signori,for the European Group for Blood and Marrow Transplantation Severe Aplastic Anemia Working Party,Andrea Bacigalupo,for the European Group for Blood and Marrow Transplantation Severe Aplastic Anemia Working Party

BLOOD WORK

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals